Pivotal Research Centers

Peoria, Arizona 85381

0 studies enrolling now · 28 studies all time

What they study most

Advanced Cancer, Advanced Malignancies, Alzheimer Disease, Alzheimer's Disease, Arthritis, Chronic Constipation, Chronic Kidney Disease, Chronic Obstructive Pulmonary Disease, Chronic Renal Failure, Chronic Renal Insufficiency, Complex Regional Pain Syndrome, Type I, Diabetes Mellitus, Type 2

Studies at this site

• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip — Stopped early
• Tanezumab In Osteoarthritis Of The Knee (2) — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation — Completed
• Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment. — Completed
• A Long-Term, Placebo-Controlled X-Ray Study Investigating the Safety and Efficacy of SD-6010 in Subjects With Osteoarthritis of the Knee — Completed
• A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies — Completed
• A Multicenter, Double Blind, Placebo-Controlled, Safety and Tolerability Study of BMS-708163 in Patients With Prodromal Alzheimer's Disease — Stopped early
• A Safety and Efficacy Study Comparing Naltrexone SR/Bupropion SR and Placebo in Obese Subjects With Type 2 Diabetes — Completed
• Pharmacokinetics and Safety Pilot Study of Single-Dose Oral and Intravenous CTAP101 in Stage 3 and 4 Chronic Kidney Disease Subjects — Completed
• VA111913 Dysmenorrhoea Efficacy and Safety Proof of Concept — Completed
• A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment — Completed
• Efficacy and Safety of Pramipexole Compared to Placebo in the Treatment of Restless Legs Syndrome (RLS) — Completed
• Study to Evaluate the Efficacy and Safety of Lenalidomide in the Treatment of Complex Regional Pain Syndrome Type 1 — Stopped early
• Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder — Completed
• Study to Evaluate the Safety and Efficacy of Inhaled PT001 in Patients With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations — Completed
• A Study of E2007 In Patients With Parkinson's Disease — Stopped early
• EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study — Completed
• The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease — Completed
• Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia — Status unconfirmed
• The Safety and Efficacy of an Investigational Drug in Delaying the Progression of Alzheimer's Disease — Stopped early
• Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease — Stopped early
• Study of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type — Completed
• A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females — Status unconfirmed
• ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) — Completed
• Evaluation of 3APS in Patients With Mild to Moderate Alzheimer's Disease — Status unconfirmed